Alcohol and cancer: what clinicians need to know

Pinterest LinkedIn Tumblr +

A recent JAMA Insights article by Morford et al. highlights the strong link between alcohol consumption and cancer risk, underscoring the importance of patient counselling in routine clinical practice.

In 2025, the US Surgeon General recommended updating alcohol warning labels to include cancer risk, counselling patients about alcohol use, and implementing alcohol intervention strategies in healthcare settings.

Globally, alcohol contributes to an estimated 740,000 cancer cases annually, with cancers of the mouth, pharynx, larynx, oesophagus, breast, colorectum, and liver most strongly implicated.

Alcohol’s carcinogenic effects are primarily mediated by its metabolite, acetaldehyde, which disrupts DNA synthesis and repair. Other mechanisms include inflammation, oxidative stress, increased estrogen levels, and facilitation of other carcinogens, such as those in tobacco. Genetic variations, such as ALDH2*2, can amplify risk, especially at lower levels of alcohol intake.

Risk increases with the amount consumed. Heavy consumption (≥5 drinks/day) is clearly associated with a higher incidence across all alcohol-related cancers.

h4 style=”text-align: center;”>Genetic testing can transform surgical decisions and family risk assessment. New tools are making it easier for all clinicians to integrate testing without specialist referrals.

Listen Now | Exclusive to The Oncology Network

Even low to moderate consumption (≤1 drink/day for women, ≤2 drinks/day for men) carries measurable risk, particularly for breast cancer, with evidence strongest for estrogen-receptor-positive tumours in postmenopausal women.

For clinicians, these findings reinforce the need for routine alcohol screening using validated tools and providing brief interventions for patients exceeding recommended limits.

Screening should identify individuals at higher risk due to genetics, family history, smoking, or pre-existing alcohol-related disease. Treatment for alcohol use disorder, when indicated, should incorporate both pharmacologic therapy and counselling.

Bottom line: Any alcohol consumption increases cancer risk, and risk rises with intake. Educating patients, monitoring alcohol use, and intervening appropriately are essential strategies for reducing alcohol-related cancer burden and promoting overall health.


Paper: Morford KLTetrault JMO’Connor PG. Alcohol and Cancer Risk. JAMA. Published online August 06, 2025. doi:10.1001/jama.2025.11229. Access online here.

Share.

About Author

Rachael Babin is a medical writer, communications expert, digital content producer and trained media host. Rachael co-founded The Oncology Network in 2014. She is Editor-in-Chief of Oncology News Australia, Publisher of The Oncology Newsletter and Host and Creator of The Oncology Podcast. Before creating The Oncology Network, Rachael worked for MOGA, COSA and an international academic publishing house.

Leave A Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.